In T-cell acute lymphoblastic leukemia (T-ALL), Teresa et al. revealed that Hes1 could decrease the protein level of PTEN and enhance the activity of the PI3K/AKT/mTOR pathway [38]. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.